168 related articles for article (PubMed ID: 36292028)
1. Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms.
Cho HG; Cho SI; Choi S; Jung W; Shin J; Park G; Moon J; Ma M; Song H; Mostafavi M; Kang M; Pereira S; Paeng K; Yoo D; Ock CY; Kim S
Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292028
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors.
Park C; Jeong DY; Choi Y; Oh YJ; Kim J; Ryu J; Paeng K; Lee SH; Ock CY; Lee HY
Front Immunol; 2022; 13():1038089. PubMed ID: 36660547
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma.
Kim DH; Lim Y; Ock CY; Park G; Park S; Song H; Ma M; Mostafavi M; Kang EJ; Ahn MJ; Lee KW; Kwon JH; Yang Y; Choi YH; Kim MK; Ji JH; Yun T; Kim SB; Keam B
Head Neck; 2023 Dec; 45(12):3086-3095. PubMed ID: 37828867
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer.
Lim Y; Choi S; Oh HJ; Kim C; Song S; Kim S; Song H; Park S; Kim JW; Kim JW; Kim JH; Kang M; Kang SB; Kim DW; Oh HK; Lee HS; Lee KW
NPJ Precis Oncol; 2023 Nov; 7(1):124. PubMed ID: 37985785
[TBL] [Abstract][Full Text] [Related]
5. Pathological Findings of the Host Immune Reaction in the Tumor Microenvironment of Gastroenteropancreatic Neuroendocrine Neoplasms.
Hasegawa S; Kobayashi N; Okubo N; Tokuhisa M; Goto A; Kurita Y; Sato T; Hosono K; Endo I; Nakajima A; Ichikawa Y
Intern Med; 2021 Apr; 60(7):977-983. PubMed ID: 33162477
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma.
Chen H; Molberg K; Strickland AL; Castrillon DH; Carrick K; Jiang Q; Niu S; Rivera-Colon G; Gwin K; Hinson S; Lea J; Miller DS; Zheng W; Lucas E
Am J Surg Pathol; 2020 Aug; 44(8):1050-1060. PubMed ID: 32384321
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance.
Xin H; Zhou C; Wang G; Liu Y; Zhang J; Liu Y; Li B; Zhang J; Su M; Li Z; Wang G
Heliyon; 2023 Feb; 9(2):e13048. PubMed ID: 36814622
[TBL] [Abstract][Full Text] [Related]
8. Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.
Park S; Ock CY; Kim H; Pereira S; Park S; Ma M; Choi S; Kim S; Shin S; Aum BJ; Paeng K; Yoo D; Cha H; Park S; Suh KJ; Jung HA; Kim SH; Kim YJ; Sun JM; Chung JH; Ahn JS; Ahn MJ; Lee JS; Park K; Song SY; Bang YJ; Choi YL; Mok TS; Lee SH
J Clin Oncol; 2022 Jun; 40(17):1916-1928. PubMed ID: 35271299
[TBL] [Abstract][Full Text] [Related]
9. Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.
Cavalcanti E; Armentano R; Valentini AM; Chieppa M; Caruso ML
Cell Death Dis; 2017 Aug; 8(8):e3004. PubMed ID: 28837143
[TBL] [Abstract][Full Text] [Related]
10. Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder.
Wang B; Pan W; Yang M; Yang W; He W; Chen X; Bi J; Jiang N; Huang J; Lin T
Cancer Sci; 2019 Feb; 110(2):489-498. PubMed ID: 30548363
[TBL] [Abstract][Full Text] [Related]
11. Concordance, Correlation, and Clinical Impact of Standardized PD-L1 and TIL Scoring in SCCHN.
De Keukeleire SJ; Vermassen T; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Ferdinande L; Rottey S
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626035
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Tumor-Infiltrating Lymphocytes, PD-L1 Expression, Driver Mutations and Clinical Outcome Parameters in Non-Small Cell Lung Cancer Adenocarcinoma in Patients with a Limited to no Smoking History.
Mignon S; Willard-Gallo K; Van den Eynden G; Salgado R; Decoster L; Marien KM; Vansteenkiste JF; Teugels E; De Grève J
Pathol Oncol Res; 2020 Apr; 26(2):1221-1228. PubMed ID: 31228073
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.
Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM
Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single-center, retrospective, longitudinal cohort study.
Kim DH; Lim Y; Kim S; Ock CY; Youk J; Kim M; Kim TM; Kim DW; Kim HJ; Koh J; Jung KC; Na KJ; Kang CH; Keam B
Thorac Cancer; 2023 Oct; 14(30):3001-3011. PubMed ID: 37675597
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 protein expression in relation to recurrence score values in early-stage ER + breast cancer.
Rozenblit M; Blenman K; Harigopal M; Reisenbichler E; Singh K; Qing T; Ibrahim E; Ramkissoon S; Asmelash S; Lin HK; Roberts M; Ross J; Huang RSP; Pusztai L
Breast Cancer Res Treat; 2022 Nov; 196(1):221-227. PubMed ID: 36028784
[TBL] [Abstract][Full Text] [Related]
16. Programmed Death-Ligand 1 Expression in Non-Small Cell Lung Carcinoma Biopsies and Its Association with Tumor Infi ltrat ing Lymphocytes and the Degree of Desmoplasia.
Tancoš V; Grendár M; Farkašová A; Huťka Z; Kviatkovská Z; Plank L
Klin Onkol; 2020; 33(1):55-65. PubMed ID: 32075390
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.
Buisseret L; Garaud S; de Wind A; Van den Eynden G; Boisson A; Solinas C; Gu-Trantien C; Naveaux C; Lodewyckx JN; Duvillier H; Craciun L; Veys I; Larsimont D; Piccart-Gebhart M; Stagg J; Sotiriou C; Willard-Gallo K
Oncoimmunology; 2017; 6(1):e1257452. PubMed ID: 28197375
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression, tumor-infiltrating lymphocytes, and mismatch repair proteins status in digestive neuroendocrine neoplasms: exploring their potential role as theragnostic and prognostic biomarkers.
Multone E; La Rosa S; Sempoux C; Uccella S
Virchows Arch; 2024 May; ():. PubMed ID: 38771338
[TBL] [Abstract][Full Text] [Related]
19. Development of an automated combined positive score prediction pipeline using artificial intelligence on multiplexed immunofluorescence images.
Vahadane A; Sharma S; Mandal D; Dabbeeru M; Jakthong J; Garcia-Guzman M; Majumdar S; Lee CW
Comput Biol Med; 2023 Jan; 152():106337. PubMed ID: 36502695
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia.
Bösch F; Brüwer K; Altendorf-Hofmann A; Auernhammer CJ; Spitzweg C; Westphalen CB; Boeck S; Schubert-Fritschle G; Werner J; Heinemann V; Kirchner T; Angele M; Knösel T
Endocr Relat Cancer; 2019 Mar; 26(3):293-301. PubMed ID: 30608901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
